Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
Gimme Care vs REMEVi
Gimme Care and REMEVi both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Gimme Care
Higher scoreRanked #24 for women · Grade B
Luna Fit
Best for: Women who want low, transparent pricing on both molecules from a LegitScript-accredited, all-50-states provider.
Visit Gimme CareREMEVi
Ranked #32 for women · Grade B
Luna Fit
Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.
Visit REMEViThe verdict for women
Gimme Care edges out REMEVi on the Luna Fit Score, 86 to 85 (B vs B). Women who want low, transparent pricing on both molecules from a LegitScript-accredited, all-50-states provider. The reasoning behind that number is in what we found reviewing Gimme Care.
REMEVi is still a genuine option — an accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end. Weigh the six women's-health factors below against your own priorities; the REMEVi scorecard goes through each of them, and if neither of these two is the one, our ranked shortlist of REMEVi alternatives widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Gimme Care | REMEVi |
|---|---|---|
| Luna Fit Score | 86/100 · B | 85/100 · B |
| Overall rank | #24 | #32 |
| Semaglutide | $160/mo | $199/mo |
| Tirzepatide | $199/mo | $269/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Luna Fit
Gimme Care
Ranked #24 · Grade B
What we like
- Low, disclosed pricing on both molecules — $160 semaglutide, $199 tirzepatide month-to-month, and the billing-cycle toggle is on the card rather than buried
- LegitScript-accredited and available nationwide
- Tirzepatide included for insulin-resistant PCOS
The caveats
- No oral option and no brand-name access
- General program without PCOS/hormone specialization
Luna Fit
REMEVi
Ranked #32 · Grade B
What we like
- LegitScript-accredited and available in all 50 states
- Both molecules disclosed, tirzepatide for insulin-resistant PCOS
- Clear, predictable pricing
The caveats
- Higher-end pricing — $199 semaglutide, $269 tirzepatide
- No oral or brand-name option; general program without hormone specialization
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Gimme Care nor REMEVi is only worth comparing with the other. Gimme Care is also written up against Tyde Wellness, an exact tie on the Luna Fit Score — see the Gimme Care–Tyde Wellness head-to-head. REMEVi is also written up against CoreAge Rx, 8 points apart — see the REMEVi–CoreAge Rx head-to-head.
- Gimme Care vs CoreAge Rx
- Gimme Care vs Enhance MD
- Gimme Care vs Eden
- REMEVi vs yourEra
- REMEVi vs Sesame Care
- REMEVi vs HealthRX
Or browse the full comparison hub.